Reuben Laryea Odai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reuben Laryea Odai has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Anthony Alchaer
University of Kansas School of Medicine–Wichita
6 shared publicationsLaiba Sajjad
University of Kansas School of Medicine–Wichita
6 shared publicationsChukwuemeka Aghasili
Department of Internal Medicine, Geisinger Wyoming Valley Medical Center
4 shared publicationsSmith Frimpong
Department of Internal Medicine, Geisinger Wyoming Valley Medical Center
4 shared publicationsIbrahim Touffaha
Medical Student, University of Kansas-Wichita, Wichita, KS, United States
3 shared publicationsHussam Farhoud
University of Kansas School of Medicine–Wichita
2 shared publications
Latest Publications
- 3 August 2026
- Published by Taylor & Francis in Future Cardiology
- Vol. 22 (8) , 799-802
Late aortic root pseudoaneurysm after pericardial patch reconstruction for bicuspid aortic valve endocarditis: a case report
- 3 August 2026
- Published by Taylor & Francis in Future Cardiology
- Vol. 22 (8) , 799-802
Late aortic root pseudoaneurysm after pericardial patch reconstruction for bicuspid aortic valve endocarditis: a case report
- Open Access
- 23 June 2026
- Published by Elsevier in Heart & Lung
- Vol. 79, 102878
Comparative utility of median household income, social vulnerability index, and social deprivation index in predicting heart failure-related emergency department revisits: A multi-hospital cohort study
- 23 June 2026
- Published by Elsevier in Heart & Lung
- Vol. 79, 102878
Open AccessComparative utility of median household income, social vulnerability index, and social deprivation index in predicting heart failure-related emergency department revisits: A multi-hospital cohort study
- Open Access
- 21 May 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (8) , 7607-7610
Cardiovascular Outcomes With SGLT‐2 Inhibitors in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Real‐World Analysis
- 21 May 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (8) , 7607-7610
Open AccessCardiovascular Outcomes With SGLT‐2 Inhibitors in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Real‐World Analysis
- 5 May 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (5) , e70681
Trends in Cardiovascular Mortality Associated With Systemic Connective Tissue Disorders in the United States: A 22‐Year Population‐Based National Analysis (1999–2020)
Aim: To examine national trends and disparities in cardiovascular mortality associated with systemic connective tissue disorders (CTDs) in the United States from 1999 to 2020. Methods: We analyzed mortality data from the CDC WONDER database. Deaths were included where CTD (ICD‐10: M05, M06, M30–M35) was the underlying cause and cardiovascular disease was a contributing cause. Age‐adjusted mortality rates (AAMRs) per 1 000 000 were calculated using the 2000 US Standard Population. Joinpoint regression identified annual and average annual percentage changes. Analyses were stratified by sex, race/ethnicity, census region, and urbanization. Disease subgroup and state‐level analyses were performed. Results: Between 1999 and 2020, 47 752 cardiovascular deaths occurred among individuals with systemic CTDs. The national AAMR declined from 14.4 to 8.2 per 1 000 000 (AAPC: −2.68%, 95% CI: −2.89 to −2.47, p < 0.001). Females had consistently higher mortality than males (average AAMR: 13.5 vs. 5.9 per 1 000 000; p < 0.001). Non‐Hispanic Black individuals had the highest rates (average AAMR: 14.9 per 1 000 000), with widening disparities after 2008. Rural areas had higher mortality than urban areas (average AAMR: 11.4 vs. 9.9 per 1 000 000; p = 0.01). Subgroup analyses revealed heterogeneous trends across CTD subtypes, with SLE showing the slowest improvement (AAPC: −1.87%) and dermatomyositis the steepest decline (AAPC: −4.98%). State‐level AAMRs ranged 2.2‐fold, from 6.3 (District of Columbia) to 13.6 (Montana) per 1 000 000. Conclusions: Cardiovascular mortality associated with systemic CTDs has declined significantly over two decades; however, persistent racial disparities, urban–rural differences, heterogeneous disease‐specific trends, and substantial geographic variation underscore the need for targeted, equitable interventions in this high‐risk population.
- 5 May 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (5) , e70681
Trends in Cardiovascular Mortality Associated With Systemic Connective Tissue Disorders in the United States: A 22‐Year Population‐Based National Analysis (1999–2020)
Aim: To examine national trends and disparities in cardiovascular mortality associated with systemic connective tissue disorders (CTDs) in the United States from 1999 to 2020. Methods: We analyzed mortality data from the CDC WONDER database. Deaths were included where CTD (ICD‐10: M05, M06, M30–M35) was the underlying cause and cardiovascular disease was a contributing cause. Age‐adjusted mortality rates (AAMRs) per 1 000 000 were calculated using the 2000 US Standard Population. Joinpoint regression identified annual and average annual percentage changes. Analyses were stratified by sex, race/ethnicity, census region, and urbanization. Disease subgroup and state‐level analyses were performed. Results: Between 1999 and 2020, 47 752 cardiovascular deaths occurred among individuals with systemic CTDs. The national AAMR declined from 14.4 to 8.2 per 1 000 000 (AAPC: −2.68%, 95% CI: −2.89 to −2.47, p < 0.001). Females had consistently higher mortality than males (average AAMR: 13.5 vs. 5.9 per 1 000 000; p < 0.001). Non‐Hispanic Black individuals had the highest rates (average AAMR: 14.9 per 1 000 000), with widening disparities after 2008. Rural areas had higher mortality than urban areas (average AAMR: 11.4 vs. 9.9 per 1 000 000; p = 0.01). Subgroup analyses revealed heterogeneous trends across CTD subtypes, with SLE showing the slowest improvement (AAPC: −1.87%) and dermatomyositis the steepest decline (AAPC: −4.98%). State‐level AAMRs ranged 2.2‐fold, from 6.3 (District of Columbia) to 13.6 (Montana) per 1 000 000. Conclusions: Cardiovascular mortality associated with systemic CTDs has declined significantly over two decades; however, persistent racial disparities, urban–rural differences, heterogeneous disease‐specific trends, and substantial geographic variation underscore the need for targeted, equitable interventions in this high‐risk population.
- Open Access
- 16 April 2026
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 19 (2) , 37-39
Multifocal Cardiac Fibroma Discovered During Pregnancy: A Case Report
- 16 April 2026
- Published by The University of Kansas in Kansas Journal of Medicine
- Vol. 19 (2) , 37-39
Open AccessMultifocal Cardiac Fibroma Discovered During Pregnancy: A Case Report
- 15 April 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (8) , 1-21
Population-level trends in non-invasive cardiac imaging before coronary revascularization
Purpose Non-invasive cardiac testing plays a critical role in evaluating patients for coronary revascularization, yet comprehensive population-level data on utilization patterns and demographic disparities remain limited. We sought to characterize trends in non-invasive cardiac testing among patients undergoing coronary revascularization and examine variations across demographic subgroups. Methods We conducted a retrospective cohort study using the TriNetX Research Network spanning January 2016 through December 2024. The study population comprised 554,855 adults aged 18–90 years who underwent percutaneous coronary intervention or coronary artery bypass grafting at 75 healthcare organizations. We analyzed utilization trends for stress echocardiography, cardiac CT angiography (CCTA), cardiac magnetic resonance imaging (CMR), single-photon emission computed tomography (SPECT), and positron emission tomography (PET), stratified by demographics. Results SPECT remained the predominant modality, with incidence proportion increasing from 3.5% to 5.7%. CCTA increased five-fold (0.46% to 2.18%), CMR nearly tripled (0.27% to 0.79%), and PET increased five-fold (0.14% to 0.70%). Stress echocardiography declined 26% (1.19% to 0.88%). Females showed higher SPECT (6.2% vs. 5.5%) and CCTA (2.31% vs. 2.12%) incidence proportions, while males had higher CMR incidence proportion (0.82% vs. 0.72%). CMR was highest in younger patients (58.82% in adolescents), while SPECT predominated in older patients (5.7-6.0% ages 65–79). SPECT utilization was lowest in Asian patients (3.36% vs. 6.22% in White patients), while CMR was highest in Black patients (1.07% vs. 0.79% in White patients). Conclusions Non-invasive cardiac imaging evolved substantially from 2016 to 2024 within the context of pre-procedural revascularization planning, with growth in advanced modalities. Demographic disparities exhibited modality-specific patterns, underscoring the need for targeted interventions.
- 15 April 2026
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 42 (8) , 1-21
Population-level trends in non-invasive cardiac imaging before coronary revascularization
Purpose Non-invasive cardiac testing plays a critical role in evaluating patients for coronary revascularization, yet comprehensive population-level data on utilization patterns and demographic disparities remain limited. We sought to characterize trends in non-invasive cardiac testing among patients undergoing coronary revascularization and examine variations across demographic subgroups. Methods We conducted a retrospective cohort study using the TriNetX Research Network spanning January 2016 through December 2024. The study population comprised 554,855 adults aged 18–90 years who underwent percutaneous coronary intervention or coronary artery bypass grafting at 75 healthcare organizations. We analyzed utilization trends for stress echocardiography, cardiac CT angiography (CCTA), cardiac magnetic resonance imaging (CMR), single-photon emission computed tomography (SPECT), and positron emission tomography (PET), stratified by demographics. Results SPECT remained the predominant modality, with incidence proportion increasing from 3.5% to 5.7%. CCTA increased five-fold (0.46% to 2.18%), CMR nearly tripled (0.27% to 0.79%), and PET increased five-fold (0.14% to 0.70%). Stress echocardiography declined 26% (1.19% to 0.88%). Females showed higher SPECT (6.2% vs. 5.5%) and CCTA (2.31% vs. 2.12%) incidence proportions, while males had higher CMR incidence proportion (0.82% vs. 0.72%). CMR was highest in younger patients (58.82% in adolescents), while SPECT predominated in older patients (5.7-6.0% ages 65–79). SPECT utilization was lowest in Asian patients (3.36% vs. 6.22% in White patients), while CMR was highest in Black patients (1.07% vs. 0.79% in White patients). Conclusions Non-invasive cardiac imaging evolved substantially from 2016 to 2024 within the context of pre-procedural revascularization planning, with growth in advanced modalities. Demographic disparities exhibited modality-specific patterns, underscoring the need for targeted interventions.
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1779097
Neighborhood socioeconomic measures and disparities in hospitalization for atrial fibrillation among medicare beneficiaries: a national county-level analysis
Objectives: To examine associations between Social Vulnerability Index (SVI), Social Deprivation Index (SDI), and median household income, and rates of hospitalizations for atrial fibrillation (AF) among Medicare beneficiaries. Methods: We analyzed hospitalizations with AF as the principal diagnosis among Medicare beneficiaries (aged ≥65) across 3,116 US counties (2019–2021) . Age-standardized hospitalization rates were obtained from the CDC's Atlas of Heart Disease and Stroke. We examined associations between social determinants and hospitalization rates overall and stratified by sex and race/ethnicity using correlation and linear regression analyses. Results: The overall rate of hospitalization among patients with AF was 575 per 100,000 beneficiaries. Each 0.01-point increase in SVI and 1-point increase in SDI was associated with 1.6 and 1.7 additional hospitalizations per 100,000, respectively ( p < 0.001). Each $1,000 increase in median household income was associated with 1.8 fewer hospitalizations ( p < 0.001). Income effects were strongest among women (−2.3 per $1,000) and persisted across all racial/ethnic groups. SDI demonstrated superior model fit (AIC: 12,967) compared to SVI (AIC: 13,000) and income (AIC: 13,069), explaining 6.2% of variance in hospitalization rates. Conclusions: Neighborhood social determinants are strongly associated with AF hospitalization rates among Medicare beneficiaries despite near-universal coverage, with pronounced sex disparities. These findings support the use of county-level socioeconomic indices for geographic surveillance, while underscoring that patient-level longitudinal studies are needed to identify the specific drivers of these associations before clinical or policy interventions can be recommended.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1779097
Open AccessNeighborhood socioeconomic measures and disparities in hospitalization for atrial fibrillation among medicare beneficiaries: a national county-level analysis
Objectives: To examine associations between Social Vulnerability Index (SVI), Social Deprivation Index (SDI), and median household income, and rates of hospitalizations for atrial fibrillation (AF) among Medicare beneficiaries. Methods: We analyzed hospitalizations with AF as the principal diagnosis among Medicare beneficiaries (aged ≥65) across 3,116 US counties (2019–2021) . Age-standardized hospitalization rates were obtained from the CDC's Atlas of Heart Disease and Stroke. We examined associations between social determinants and hospitalization rates overall and stratified by sex and race/ethnicity using correlation and linear regression analyses. Results: The overall rate of hospitalization among patients with AF was 575 per 100,000 beneficiaries. Each 0.01-point increase in SVI and 1-point increase in SDI was associated with 1.6 and 1.7 additional hospitalizations per 100,000, respectively ( p < 0.001). Each $1,000 increase in median household income was associated with 1.8 fewer hospitalizations ( p < 0.001). Income effects were strongest among women (−2.3 per $1,000) and persisted across all racial/ethnic groups. SDI demonstrated superior model fit (AIC: 12,967) compared to SVI (AIC: 13,000) and income (AIC: 13,069), explaining 6.2% of variance in hospitalization rates. Conclusions: Neighborhood social determinants are strongly associated with AF hospitalization rates among Medicare beneficiaries despite near-universal coverage, with pronounced sex disparities. These findings support the use of county-level socioeconomic indices for geographic surveillance, while underscoring that patient-level longitudinal studies are needed to identify the specific drivers of these associations before clinical or policy interventions can be recommended.